‘Pharma Bro’ Martin Shkreli defies advice to keep quiet before Brooklyn fraud trial
“Pharma Bro” just won’t keep his mouth shut.
Even before his federal securities fraud trial began Monday, Martin Shkreli blatantly defied his attorneys’ advice to lay low. The former pharmaceutical CEO, who became a pariah after raising the cost of a life-saving drug 5,000 percent, has been preening for cameras and trolling on social media, potentially complicating his defense.
“I’m excited,” Shkreli said of the trial in a brief phone call last week to the Associated Press. “I can’t wait.”